loading...| Preferred Name | aminobenzoate potassium | |
| Synonyms |
Potaba potassium p-aminobenzoate potassium para-aminobenzoate |
|
| Definitions |
The potassium salt form of aminobenzoate, with anti-inflammatory and antifibrotic activities. Aminobenzoate potassium increases oxygen uptake at the tissue level and may enhance monoamine oxidase (MAO) activity, which requires oxygen as a substrate. Enhanced MAO activity maybe accountable for the prevention or regression of fibrosis, which may occur due to too much serotonin or too little MAO activity. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1736" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1736" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000039571 |
|
| altLabel |
Potaba potassium p-aminobenzoate potassium para-aminobenzoate |
|
| cui |
C0032820 C0543464 |
|
| Date last modified |
2006-12-15 |
|
| definition |
The potassium salt form of aminobenzoate, with anti-inflammatory and antifibrotic activities. Aminobenzoate potassium increases oxygen uptake at the tissue level and may enhance monoamine oxidase (MAO) activity, which requires oxygen as a substrate. Enhanced MAO activity maybe accountable for the prevention or regression of fibrosis, which may occur due to too much serotonin or too little MAO activity. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1736" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1736" NCI Thesaurus) |
|
| Legacy PDQ ID |
2225 |
|
| NCI ID |
C1736 |
|
| notation |
CDR0000039571 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
aminobenzoate potassium |
|
| tui |
T109 T121 |